/
J Clin Oncol
Nivolumab and doxorubicin, vinblastine, and dacarbazine in early-stage unfavorable Hodgkin Lymphoma: final analysis of the randomized german Hodgkin study group phase II NIVAHL trial
- P.J. Bröckelmann
- I. Bühnen
- J. Meissner
- K. Trautmann-Grill
- P. Herhaus
- T.V. Halbsguth
- V. Schaub
- A. Kerkhoff
- S. Mathas
- M. Bormann
- A. Dickhut
- H. Kaul
- M. Fuchs
- C. Kobe
- C. Baues
- P. Borchmann
- A. Engert
- B. von Tresckow